Home >
A HOLISTIC APPROACH TO PSORIASIS IN GOSSELIES - BELGIUM
2008/10/21 - News from patients associations
Early 2008, the Dermatology team at Clinique Notre-Dame de Grâce (Gosselies-Belgium) has initiated, in collaboration with GIPSO, a support program dedicated to patients suffering from medium to severe psoriasis.
Doctor Françoise POOT, Head of the Dermatology Service and member of the GIPSO’s Scientific Committee, invited GIPSO representatives in order to put in concrete form the MODULE PSORIASIS , which is to be integrated into their therapeutic project « BETTER BEING CENTRE », the first of its kind in the French Community of Belgium.
What is it about?
This innovative program is operated by the Clinique’s Wellbeing Center
(Centre Mieux-Etre), a holistic, integrative and complementary medical
center offering since 2006 multidisciplinary therapy and support
programs in areas such as obesity, stress, fibromyalgia, cancer, giving
up smoking.
The aim of a Center for holistic medecine (taking into account the person in all his, or her, dimesions) is to consider all aspects of the patient’s physical as well as psychological suffering. Indeed numerous patients complain about an approach split between various disciplines, whereas the whole of the subject is to be examined.
A diagnosis, followed by a therapeutic plan, must be established in a multidisciplinary perspective for patients who are taken charge of in the long term by several intervening parties.
Located in a hospital, it is a center for curative medecine run by a pluridisciplinary team of physicians and paramedics who associate a number of complementary techniques based on objective and scientific purposes such as physical activity, diet advice, relaxation, aquagym, beauty care, psychological help .....
The efficiency of the treatment of a patient within the framework of the Centre’s activities requires from the patient a regular attendance to the totality of the disciplines that concern him and that have been planned by common consent by the various intervening parties together with the General Practitioner.
How does the centre work?
The functioning principle is based on three phases:
- The phase of multidisciplinary orientation : all the intervening parties confer an determine the best way to take charge of the patient after a thorough examination of the physical or psychological health, taking into account the patient’s expectations; the team then work out an evaluation.
- The phase of multidisciplinary taking in charge : once the evaluation is known, the therapeutic proposition will be related to the problem to treat, taking into account the possibilities of the patient and the frequency of the prestations to ensure real progress.
- A phase of intermediary evaluation: after 4 to 6 weeks, the coordinating doctor assesses with the patient the evolution and the progress achieved in order to consider possible changes in the treatment.
Are you suffering from psoriasis?
We know this affection frequently modifies the image you can have of yourself, damages your quality of life, can have consequences on your professional life as well as on familial and social relationships. It condemns patients to assume exacting and sometimes fastidious treatments.
The Better Being Centre proposes a learning and support programme which complements the medical treatment to gain better understanding of the illness, to overcome its servitudes and to manage the medical care prescribed by the physician in the best of ways.
The Psoriasis program is meant to help to better cope with the disease and thus improve quality of life.
The program begins with a short individual assessment phase with the following practitioners: psychologist, coordinating physician, muscle and joints specialist, dietician (in case of associated obesity).
The assessment leads to a proposal to enroll in the therapeutic pathway and join a group of about eight patients, for a period of ten to twelve weeks.
Group activities are organized once or twice a week; they include
- Information sessions, jointly organized with GIPSO :
- understand psoriasis, its relation to stress and quality of life
- understand the benefits of sport and physical activity
- sessions to learn and experience relaxation and build a positive relationship with one’s body
- cosmetic skin care workshops
- water gym
- an individual follow-up visit with the coordinating physician
- discussion and evaluation at the end of the program.
This initiative of the medical team of the Clinique Notre-Dame de Grâce in Gosselies
looks innovating and likely to bring help and comfort.
For further information :
Clinique Notre-Dame de Grâce : Dr Françoise Poot
Tel : 071 / 379.654 francoise.poot@cndg.be; www.cndg.be
GIPSO: info@gipso.info ; www.gipso.info (Secrétariat): Tel: 04 365 07 38
Antoinette ROMEO
Jules LEROUX
SPIN Presentation
Recent news
- 2019/10/29 Focus on...
- 2019/08/12 Focus on...
Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis
- 2019/06/03 Focus on...
- 2019/05/21 Focus on...
Prof Nelida Aurora Raimondo
News from the web office
- 2016/10/29
- 2016/05/26
- 2016/02/20
Events
- 2019/04/18 Focus on...
- 2018/02/21
News from medical groups
- 2018/04/18
- 2017/06/21
News from patients associations
- 2017/02/08
- 2016/05/26
Recent publications on Psoriasis and Atopic Dermatitis
on Psoriasis
Conformational dynamics in interleukin 17A and 17F functional complexes is a key determinant of receptor A affinity and specificity.
Cytokine.
2021 Jun , 142:155476.
The proinflammatory cytokines IL-17A and IL-17F have been identified as key drivers of a range of human inflammatory diseases, such as psoriasis, which has led to several therapeutic antibodies targeted at IL-17A. The two cytokines have been shown to tightly associate as functional homo and hetero dimers, which induce signalling via the formation of a cell surface signalling complex with a single copy of both IL-17RA and IL-17RC. Striking differences in affinity have been observed for (...)
see on pubmed
Protective Effects of Polyvinylpyrrolidone-Wrapped Fullerene Against Nitric Oxide/Peroxynitrite-Induced Cellular Injury in Human Skin Keratinocytes.
J Nanosci Nanotechnol.
2021 Sep 01, 21, (9):4579-4585.
Excess ultraviolet (UV) exposure accelerates skin inflammation, melanogenesis, wrinkle formation, photoaging, and carcinogenesis through oxidative stress and deoxyribonucleic acid damage. These deleterious effects to skin are closely associated with UV-induced reactive oxygen species (ROS) and reactive nitrogen species (RNS) produced via nitric oxide (NO) generation. RNS are known to be responsible for various skin disorders, such as erythema, melanin production, reduced barrier function, (...)
see on pubmed
Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways.
Bioengineered.
2021 Dec , 12, (1):183-195.
Psoriasis is a chronic inflammatory skin disease that affects approximately 2% of worldwide population, and causing long-term troubles to the patients. Therefore, it is urgent to develop safe and effective therapeutic drugs. Catalpol is a natural iridoid glucoside, that has several remarkable pharmacological effects, however, whether catalpol can alleviated psoriasis has not been explored. The goal of the present work is to study the role of catalpol in psoriasis in vivo and in vitro. (...)
see on pubmed
on Atopic Dermatitis
Viral metagenomic identification of a novel anellovirus in blood sample of a child with atopic dermatitis.
J Med Virol.
2021 Jun , 93, (6):4038-4041.
Here, using viral metagenomics, a novel anellovirus with strain name HuAV-zj-ad1 was detected in blood sample from a child with atopic dermatitis. The complete genome sequence of HuAV-zj-ad1 was determined and fully characterized. The circular genome of HuAV-zj-ad1 is 2841 nt in length and includes four polyprotein ORFs. Phylogenetic analysis and pairwise sequence comparisons based on the amino acid sequences of ORF1, ORF2, ORF3, ORF4 indicated that HuAV-zj-ad1 belonged to a novel species (...)
see on pubmed
Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma.
Auris Nasus Larynx.
2021 Jun , 48, (3):353-360.
Eosinophilic otitis media (EOM) is an intractable otitis media mostly associated with bronchial asthma. Dupilumab, an anti-interleukin (IL)-4 receptor (R)α, is effective and has been approved for use in patients with moderate to severe bronchial asthma, atopic dermatitis and chronic rhinosinusitis with nasal polyposis, whose diseases are not controlled by previous treatments including other molecular targeted drugs. We aimed to assess efficacy of dupilumab in three EOM patients with (...)
see on pubmed
Methicillin-resistant from infected skin lesions present several virulence genes and are associated with the CC30 in Brazilian children with atopic dermatitis.
Virulence.
2021 12 , 12, (1):260-269.
Atopic dermatitis (AD) is a chronic inflammatory skin disease and colonization by may affect up to 100% of these patients. Virulent and resistant isolates can worsen AD patient clinical condition and jeopardize the treatment. We aimed to detect virulence genes and to evaluate the biofilm production of isolates from infected skin lesions of children with AD. Methicillin resistance was detected by phenotypic and molecular tests and the virulence genes were detected by PCR. Biofilm formation (...)
see on pubmed